Stockreport

Waldencast Reports Q2 2024 Financial Results

Waldencast plc - Class A Ordinary Share  (WALD) 
PDF $63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64 [Read more]